Network Lead Academic Participating Site Grant from the Roswell Cancer Inst.

描述(由申请者提供)：罗斯威尔公园癌症研究所几十年来一直为国家合作团体做出贡献，具有悠久的传统。这些贡献是科学的、管理的和参与性的(在过去的5年里，有1200多名患者参加了合作小组试验)。多年来，贡献是始终如一的，也是众多的。本申请总结了其4个合作绩效指标(Levine博士/Adjei博士/Lele博士/Singh博士)和RPCI成员的意图，以维持其对合作小组研究固有的许多优势的承诺：治疗进展；更好地了解癌症生物学；癌症预防；改善癌症患者生活质量的手段；新药和放射学、放射和外科技术的试验；建立新的细胞和分子进展与患者的预测、预后和治疗方法的相关性；以及促进患者倡导。RPCI的调查人员及其辅助工作人员充分认识到及时和准确地提交数据和标本对实现这些目标至关重要。

DESCRIPTION (provided by applicant): The Roswell Park Cancer Institute has had a long tradition of contributing to the national cooperative groups over many decades. Those contributions have been scientific, administrative, and participatory (over 1200 patients have been enrolled in cooperative group trials over the last 5 years). Contributions have been consistent and numerous over the years. This application summarizes the intent of its 4 Co-PIs (Dr. Levine/Dr. Adjei/Dr. Lele/Dr. Singh) and the membership of RPCI to sustain its commitment to the many strengths inherent to cooperative group research: therapeutic advances; a better understanding of the biology of cancer; cancer prevention; means to improve the quality of life of cancer patients; piloting of new drugs and radiology and radiation and surgical techniques; establishing the relevance of new cellular and molecular advances to the predictive, prognostic, and therapeutic approaches to patients; and the advancement of patient advocacy. Investigators at RPCI and its supporting staff fully recognize the essential importance of the timely and accurate submission of data and specimens to achieve these aims.